{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:45:20Z","timestamp":1761518720575},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.diabres.2003.08.003","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T23:04:32Z","timestamp":1065913472000},"page":"187-195","source":"Crossref","is-referenced-by-count":17,"title":["Therapy after single oral agent failure: adding a second oral agent or an insulin mixture?"],"prefix":"10.1016","volume":"62","author":[{"given":"James K.","family":"Malone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara N.","family":"Campaigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvonko","family":"Milicevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2003.08.003_BIB1","doi-asserted-by":"crossref","unstructured":"R.A. DeFronzo, A.M. Goodman, and the Multicenter Metformin Study Group, Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus, N. Engl. J. Med. 333 (1995) 541\u2013549.","DOI":"10.1056\/NEJM199508313330902"},{"key":"10.1016\/j.diabres.2003.08.003_BIB2","unstructured":"European Diabetes Policy Group, A desktop guide to type 2 diabetes mellitus, Ann. Intern. Med. 16 (1999) 716\u2013730."},{"key":"10.1016\/j.diabres.2003.08.003_BIB3","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993) 977\u2013986.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1016\/j.diabres.2003.08.003_BIB4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus. A randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diab. Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2003.08.003_BIB5","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group, UK Prospective Diabetes Study 33: Intensive blood\u2013glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes, Lancet 352 (1998) 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.diabres.2003.08.003_BIB6","doi-asserted-by":"crossref","unstructured":"American Diabetes Association, Postprandial blood glucose, Diabetes Care 24 (2001) 775\u2013778.","DOI":"10.2337\/diacare.24.4.775"},{"key":"10.1016\/j.diabres.2003.08.003_BIB7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/diabetes.46.2.265","article-title":"Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group","volume":"46","author":"Anderson","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2003.08.003_BIB8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archinte.157.11.1249","article-title":"Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group","volume":"157","author":"Anderson Jr","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diabres.2003.08.003_BIB9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diacare.22.8.1258","article-title":"Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation","volume":"22","author":"Roach","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2003.08.003_BIB10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0149-2918(00)88307-1","article-title":"Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, Insulin Lispro Mix25 and Insulin Lispro Mix50","volume":"21","author":"Roach","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1016\/j.diabres.2003.08.003_BIB11","unstructured":"J.C. Pickup, G. Williams (Eds.), Classification and diagnosis of diabetes mellitus and impaired glucose tolerance, in: Textbook of Diabetes, vol. 1, Blackwell Scientific Publications, Oxford, UK, 1991, p. 39."},{"key":"10.1016\/j.diabres.2003.08.003_BIB12","unstructured":"S.A. Ross, B. Zinman, R.V. Campos, T. Strack, Canadian Lispro Study Group, A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents, Clin. Invest. Med. 24 (2001) 292\u2013298."},{"key":"10.1016\/j.diabres.2003.08.003_BIB13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2337\/diacare.23.9.1236","article-title":"Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group","volume":"23","author":"Bastyr","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2003.08.003_BIB14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2337\/diacare.24.5.897","article-title":"Disturbances of glucose metabolism in men referred for coronary arteriography: postload glycemia as a predictor of coronary atheriosclerosis","volume":"24","author":"Kowalska","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2003.08.003_BIB15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2000-5802","article-title":"Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?","volume":"108","author":"Temelkova-Kurktschiev","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822703001815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822703001815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T05:21:06Z","timestamp":1550640066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822703001815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0168822703001815"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2003.08.003","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}